People with Platinum-Resistant Recurrent Ovarian Cancer are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai. You may be eligible to participate in this study if you: Are a female at least 18 years of age Have histologically confirmed and documented recurrent ovarian, fallopian tube, or peritoneal […]
People with Ovarian Cancer are asked to participate in a research study being conducted by Monter Cancer Center. You may be eligible to participate in this study if you: • Understand the study procedures and agrees to participate in the study by providing written informed consent. • Are currently receiving treatment with niraparib • Are […]
Women with Ovarian Cancer are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai. You may be eligible to participate in this study if you: Are a female at least 18 years of age Have a confirmed diagnosis of high-grade serous EOC, primary peritoneal cancer, or fallopian […]
Ovarian Cancer (OVATION 2)
People with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer are asked to participate in a research study being conducted by Northwell Health. You may be eligible to participate in this study if you: Are a female at least 18 years of age or older Have histologic diagnosis of epithelial ovarian, fallopian tube, or […]
Platinum-Resistant Ovarian Cancer
A Study of Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With a Safety Run-in of a Dose-Dense Regimen (innovaTV 208) Women with platinum resistant ovarian cancer are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai. You may be eligible to participate in this study if […]